MAPK8 and breast cancer: The breast cancer cells were pre-treated with 10 μM SB203580 (p38 MAPK inhibitor) or SP600125 (JNK inhibitor) for 1 h, followed by PTER-ITC treatment for an additional 24 h, and the percentage of dead cells was determined in an MTT assay.